Hepatology, is experiencing significant and extraordinary changes. This is the context for the Conference Future Scenarios in Hepatology.

Today it is possible to permanently eradicate, in more than 90% of cases, the C virus, one of the most frequent causes of chronic liver disease up to cirrhosis and its complications, and new drugs are on the way to further optimize these results. This is a momentous event: those who discovered this virus in 1989 can now witness its elimination. This will have a strong and significant societal impact, although those cases of cirrhotic disease that were already advanced before eradication of the virus was possible and will still need monitoring and treatment will remain.

Another area that is experiencing profound changes is that of hepatic steatosis, often referred to as NAFLD, an English acronym for nonalcoholic liver steatosis. The international scientific community believes that in about 15 years this metabolic liver disease will be the most prevalent liver disease. This condition, found in an important way since pediatric age, has increasingly highlighted its potential to evolve to cirrhosis and to all its complications. Fact that has an inevitable fallout to social level as it correlates with daily habits and lifestyles.

A reading on "What's New in CBP Treatment" will be held at the end of the second day of the conference.

The conference is an opportunity to explore these issues from the perspective of the aspects of prevention, early diagnosis and treatment options.